Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > OPT Opthea > Detailed Quotes

OPT Opthea

5.513
-0.032-0.58%
Trading Session 10/07 14:44 ET
High
5.688
Open
5.688
Turnover
5.75K
Low
5.513
Pre Close
5.545
Volume
1.03K
Market Cap
279.05M
P/E(TTM)
Loss
52wk High
8.500
Shares
50.62M
P/E(Static)
Loss
52wk Low
4.734
Float Cap
185.40M
Bid/Ask %
53.85%
Historical High
16.230
Shs Float
33.63M
Volume Ratio
0.31
Historical Low
4.734
Dividend TTM
--
Div Yield TTM
--
P/B
5.81
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
3.17%
Avg Price
5.572
Lot Size
1
Float Cap
185.40M
Bid/Ask %
53.85%
Historical High
16.230
Shs Float
33.63M
Volume Ratio
0.31
Historical Low
4.734
Dividend TTM
--
P/B
5.81
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
3.17%
Avg Price
5.572
Lot Size
1
Price Forecast

No Data

News

Comment

No More
Company Overview More
Opthea Ltd. is a clinical stage biopharmaceutical company that engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It focuses on treating neovascular age-related macular degeneration and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. The company was founded on October 17, 1984 and is headquartered in South Yarra, Australia.
CEO: Dr. Megan Baldwin
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...